Technology
Health
Pharmaceutical
SIGA Technologies
$5.989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.03 (-0.50%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell SIGA and other stocks, options, ETFs, and crypto commission-free!
About
SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Read More It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.
Employees
41
Headquarters
New York, New York
Founded
1995
Market Cap
485.39M
Price-Earnings Ratio
1.17
Dividend Yield
0.00
Average Volume
260.50K
High Today
$6.15
Low Today
$5.92
Open Price
$6.02
Volume
91.77K
52 Week High
$8.47
52 Week Low
$4.68
Collections
Technology
Health
Pharmaceutical
Medical
US
North America
News
Yahoo FinanceFeb 21
SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA’s Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 9:00 am ET on Friday, March 1, 2019 in New York. To access the live webcast and a copy of the presentation, please visit the Investor Relations section of the Company’s website, under Events & Pr...
Price Paid on Robinhood
6% Lower
Right Now
52 Week Low
$4.68
Average Price Paid
$6.38
52 Week High
$8.47
Earnings
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 3, After Hours